vs
OneStream, Inc.（OS）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是OneStream, Inc.的1.3倍（$207.3M vs $163.7M），OneStream, Inc.净利率更高（0.6% vs -62.0%，领先62.6%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 23.6%），OneStream, Inc.自由现金流更多（$25.6M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 21.8%）
Blue Stream面向美国佛罗里达州科勒尔斯普林斯、韦斯顿两地的居民及商业客户，提供有线电视、有线固话、数字录像服务，以及最高速率达1G的宽带互联网接入服务，深耕当地通信市场，为用户提供稳定可靠的多元通信解决方案。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
OS vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $163.7M | $207.3M |
| 净利润 | $999.0K | $-128.6M |
| 毛利率 | 69.8% | — |
| 营业利润率 | -3.2% | -54.7% |
| 净利率 | 0.6% | -62.0% |
| 营收同比 | 23.6% | 25.9% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | — | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $163.7M | $207.3M | ||
| Q3 25 | $154.3M | $159.9M | ||
| Q2 25 | $147.6M | $166.5M | ||
| Q1 25 | $136.3M | $139.3M | ||
| Q4 24 | $132.5M | $164.6M | ||
| Q3 24 | $129.1M | $139.5M | ||
| Q2 24 | $117.5M | $147.0M | ||
| Q1 24 | $110.3M | $108.8M |
| Q4 25 | $999.0K | $-128.6M | ||
| Q3 25 | $-8.8M | $-180.4M | ||
| Q2 25 | $-18.4M | $-115.0M | ||
| Q1 25 | $-24.0M | $-151.1M | ||
| Q4 24 | — | $-133.2M | ||
| Q3 24 | $-171.9M | $-133.5M | ||
| Q2 24 | $-7.8M | $-131.6M | ||
| Q1 24 | $-5.0M | $-170.7M |
| Q4 25 | 69.8% | — | ||
| Q3 25 | 68.1% | — | ||
| Q2 25 | 68.6% | — | ||
| Q1 25 | 68.0% | — | ||
| Q4 24 | 66.8% | — | ||
| Q3 24 | 50.1% | — | ||
| Q2 24 | 68.5% | — | ||
| Q1 24 | 69.1% | — |
| Q4 25 | -3.2% | -54.7% | ||
| Q3 25 | -11.3% | -106.9% | ||
| Q2 25 | -21.8% | -64.8% | ||
| Q1 25 | -29.3% | -102.6% | ||
| Q4 24 | -35.8% | -74.3% | ||
| Q3 24 | -197.6% | -94.6% | ||
| Q2 24 | -9.8% | -79.1% | ||
| Q1 24 | -4.9% | -151.9% |
| Q4 25 | 0.6% | -62.0% | ||
| Q3 25 | -5.7% | -112.8% | ||
| Q2 25 | -12.5% | -69.0% | ||
| Q1 25 | -17.6% | -108.5% | ||
| Q4 24 | — | -80.9% | ||
| Q3 24 | -133.1% | -95.7% | ||
| Q2 24 | -6.7% | -89.5% | ||
| Q1 24 | -4.5% | -156.8% |
| Q4 25 | — | $-1.28 | ||
| Q3 25 | — | $-1.81 | ||
| Q2 25 | — | $-1.17 | ||
| Q1 25 | — | $-1.57 | ||
| Q4 24 | — | $-1.34 | ||
| Q3 24 | $-1.06 | $-1.40 | ||
| Q2 24 | — | $-1.52 | ||
| Q1 24 | — | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $693.6M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $504.7M | $-80.0M |
| 总资产 | $1.0B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $693.6M | $421.0M | ||
| Q3 25 | $653.9M | $202.5M | ||
| Q2 25 | $652.1M | $176.3M | ||
| Q1 25 | $593.9M | $127.1M | ||
| Q4 24 | $544.2M | $174.0M | ||
| Q3 24 | $495.5M | $150.6M | ||
| Q2 24 | $140.5M | $480.7M | ||
| Q1 24 | — | $112.3M |
| Q4 25 | $504.7M | $-80.0M | ||
| Q3 25 | $472.1M | $9.2M | ||
| Q2 25 | $458.2M | $151.3M | ||
| Q1 25 | $412.9M | $144.2M | ||
| Q4 24 | $386.2M | $255.0M | ||
| Q3 24 | $458.2M | $346.8M | ||
| Q2 24 | $97.5M | $432.4M | ||
| Q1 24 | $102.5M | $140.3M |
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $949.4M | $1.2B | ||
| Q2 25 | $910.5M | $1.3B | ||
| Q1 25 | $867.3M | $1.3B | ||
| Q4 24 | $823.2M | $1.5B | ||
| Q3 24 | $750.1M | $1.5B | ||
| Q2 24 | $379.7M | $1.6B | ||
| Q1 24 | — | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.8M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $25.6M | $-100.8M |
| 自由现金流率自由现金流/营收 | 15.7% | -48.6% |
| 资本支出强度资本支出/营收 | 0.1% | 0.5% |
| 现金转化率经营现金流/净利润 | 25.79× | — |
| 过去12个月自由现金流最近4个季度 | $95.6M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $25.8M | $-99.8M | ||
| Q3 25 | $5.0M | $-91.4M | ||
| Q2 25 | $29.7M | $-108.3M | ||
| Q1 25 | $36.2M | $-166.5M | ||
| Q4 24 | — | $-79.3M | ||
| Q3 24 | $2.4M | $-67.0M | ||
| Q2 24 | $8.1M | $-77.0M | ||
| Q1 24 | $25.5M | $-190.7M |
| Q4 25 | $25.6M | $-100.8M | ||
| Q3 25 | $4.8M | $-92.7M | ||
| Q2 25 | $29.4M | $-110.7M | ||
| Q1 25 | $35.8M | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | $1.3M | $-68.6M | ||
| Q2 24 | $7.7M | $-79.0M | ||
| Q1 24 | $24.9M | $-193.9M |
| Q4 25 | 15.7% | -48.6% | ||
| Q3 25 | 3.1% | -58.0% | ||
| Q2 25 | 19.9% | -66.5% | ||
| Q1 25 | 26.3% | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | 1.0% | -49.2% | ||
| Q2 24 | 6.6% | -53.7% | ||
| Q1 24 | 22.5% | -178.2% |
| Q4 25 | 0.1% | 0.5% | ||
| Q3 25 | 0.1% | 0.8% | ||
| Q2 25 | 0.2% | 1.5% | ||
| Q1 25 | 0.3% | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | 0.8% | 1.2% | ||
| Q2 24 | 0.3% | 1.4% | ||
| Q1 24 | 0.6% | 3.0% |
| Q4 25 | 25.79× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OS
| Subscription And Circulation | $150.3M | 92% |
| Professional Services And Other | $9.4M | 6% |
| License | $4.0M | 2% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
